If youre using BPC-157 to recover from injury, surgery, or chronic inflammation, its not just about how long it stays in your bloodstreamit's about how effectively it sets your body in motion to regenerate tissue and restore function
doi: 10.1007/s11095-010-0073-2, 243
A 30-year-old likely has far fewer senescent cells than a 60-year-old, which means: Younger individuals may notice less from FOXO4-DRI simply because there are fewer target cells to clear Older individuals or those with conditions associated with accelerated senescence (chronic inflammation, metabolic syndrome, prior chemotherapy) may have more to gain and more pronounced initial side effects from a larger clearance event Overall Health and Immune Function The immune system must clear apoptotic cells after FOXO4-DRI triggers their death
If any of these things happen, it might be time to switch: Either your insulin dose goes up or down a lot
Search strategy This scoping review was conducted in accordance with the preferred reporting items for systematic reviews and meta-analyses extended for scoping reviews (PRISMA-ScR)
